Latest Insider Transactions at Vor Biopharma Inc. (VOR)
This section provides a real-time view of insider transactions for Vor Biopharma Inc. (VOR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Vor Biopharma Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Vor Biopharma Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 06
2024
|
Tirtha Chakraborty CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
875
-0.51%
|
$0
$0.86 P/Share
|
|
Nov 06
2024
|
Robert Ang PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,361
-0.3%
|
$0
$0.86 P/Share
|
|
Nov 06
2024
|
Eyal C. Attar CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
999
-1.08%
|
$0
$0.86 P/Share
|
|
Nov 06
2024
|
Amy Quinlan Vice President of Finance |
SELL
Payment of exercise price or tax liability
|
Direct |
206
-0.41%
|
$0
$0.86 P/Share
|
|
Nov 01
2024
|
Robert Ang PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,751
-0.35%
|
$0
$0.8 P/Share
|
|
Nov 01
2024
|
Eyal C. Attar CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,146
-1.22%
|
$0
$0.8 P/Share
|
|
Nov 01
2024
|
Tirtha Chakraborty CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
986
-0.57%
|
$0
$0.8 P/Share
|
|
Nov 01
2024
|
Amy Quinlan Vice President of Finance |
SELL
Payment of exercise price or tax liability
|
Direct |
343
-0.67%
|
$0
$0.8 P/Share
|
|
Sep 03
2024
|
Amy Quinlan Vice President of Finance |
SELL
Payment of exercise price or tax liability
|
Direct |
4,402
-7.97%
|
$0
$0.83 P/Share
|
|
Sep 03
2024
|
Robert Ang PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
12,657
-1.57%
|
$0
$0.83 P/Share
|
|
Sep 03
2024
|
Tirtha Chakraborty CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
5,576
-3.14%
|
$0
$0.83 P/Share
|
|
Aug 06
2024
|
Amy Quinlan Vice President of Finance |
SELL
Payment of exercise price or tax liability
|
Direct |
206
-0.37%
|
$0
$0.87 P/Share
|
|
Aug 06
2024
|
Robert Ang PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,361
-0.29%
|
$0
$0.87 P/Share
|
|
Aug 06
2024
|
Eyal C. Attar CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
999
-1.05%
|
$0
$0.87 P/Share
|
|
Aug 06
2024
|
Tirtha Chakraborty CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
876
-0.49%
|
$0
$0.87 P/Share
|
|
Aug 01
2024
|
Amy Quinlan Vice President of Finance |
SELL
Payment of exercise price or tax liability
|
Direct |
343
-0.61%
|
$0
$0.94 P/Share
|
|
Aug 01
2024
|
Tirtha Chakraborty CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
985
-0.55%
|
$0
$0.94 P/Share
|
|
Aug 01
2024
|
Eyal C. Attar CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,146
-1.19%
|
$0
$0.94 P/Share
|
|
Aug 01
2024
|
Robert Ang PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,751
-0.34%
|
$0
$0.94 P/Share
|
|
Jun 03
2024
|
Eyal C. Attar CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
14,645
-13.23%
|
$14,645
$1.39 P/Share
|
|
May 06
2024
|
Robert Ang PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,361
-0.29%
|
$2,361
$1.75 P/Share
|
|
May 06
2024
|
Tirtha Chakraborty CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
875
-0.49%
|
$875
$1.75 P/Share
|
|
May 06
2024
|
Eyal C. Attar CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
999
-0.89%
|
$999
$1.75 P/Share
|
|
May 06
2024
|
Nathan D. Jorgensen CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
834
-0.44%
|
$834
$1.75 P/Share
|
|
May 01
2024
|
Tirtha Chakraborty CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
985
-0.54%
|
$985
$1.77 P/Share
|
|
May 01
2024
|
Nathan D. Jorgensen CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
917
-0.48%
|
$917
$1.77 P/Share
|
|
May 01
2024
|
Eyal C. Attar CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,146
-1.02%
|
$1,146
$1.77 P/Share
|
|
May 01
2024
|
Robert Ang PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,751
-0.34%
|
$2,751
$1.77 P/Share
|
|
Mar 01
2024
|
Robert Ang PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
12,657
-1.53%
|
$25,314
$2.27 P/Share
|
|
Mar 01
2024
|
Tirtha Chakraborty CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
5,576
-2.99%
|
$11,152
$2.27 P/Share
|
|
Mar 01
2024
|
Nathan D. Jorgensen CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
6,310
-3.2%
|
$12,620
$2.27 P/Share
|
|
Feb 06
2024
|
Eyal C. Attar CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,180
-1.03%
|
$2,360
$2.32 P/Share
|
|
Feb 06
2024
|
Tirtha Chakraborty CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,033
-0.55%
|
$2,066
$2.32 P/Share
|
|
Feb 06
2024
|
Nathan D. Jorgensen CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
985
-0.5%
|
$1,970
$2.32 P/Share
|
|
Feb 06
2024
|
Robert Ang PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,788
-0.34%
|
$5,576
$2.32 P/Share
|
|
Jan 29
2024
|
Robert Ang PRESIDENT AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+15.29%
|
-
|
|
Jan 29
2024
|
Tirtha Chakraborty CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
53,750
+22.26%
|
-
|
|
Jan 29
2024
|
Eyal C. Attar CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
62,500
+35.4%
|
-
|
|
Jan 29
2024
|
Nathan D. Jorgensen CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+20.12%
|
-
|
|
Nov 06
2023
|
Tirtha Chakraborty CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
876
-0.65%
|
$876
$1.82 P/Share
|
|
Nov 06
2023
|
Eyal C. Attar CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
999
-1.9%
|
$999
$1.82 P/Share
|
|
Nov 06
2023
|
Nathan D. Jorgensen CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
834
-0.57%
|
$834
$1.82 P/Share
|
|
Nov 06
2023
|
Robert Ang PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,361
-0.35%
|
$2,361
$1.82 P/Share
|
|
Sep 01
2023
|
Tirtha Chakraborty CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
5,576
-3.97%
|
$11,152
$2.67 P/Share
|
|
Sep 01
2023
|
Nathan D. Jorgensen CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
6,310
-4.13%
|
$12,620
$2.67 P/Share
|
|
Sep 01
2023
|
Robert Ang PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
12,657
-1.82%
|
$25,314
$2.67 P/Share
|
|
Aug 07
2023
|
Nathan D. Jorgensen CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
834
-0.54%
|
$1,668
$2.67 P/Share
|
|
Aug 07
2023
|
Tirtha Chakraborty CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
875
-0.62%
|
$1,750
$2.67 P/Share
|
|
Aug 07
2023
|
Robert Ang PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,361
-0.34%
|
$4,722
$2.67 P/Share
|
|
Aug 07
2023
|
Eyal C. Attar CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
999
-1.87%
|
$1,998
$2.67 P/Share
|